Toll-like Receptor Signaling Inhibits Hepatitis B Virus Replication in Vivo

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2005 May 14

PMID 15890966

Citations 189

Authors

Masanori Isogawa

Michael D Robek

Yoshihiro Furuichi

Francis V Chisari

Affiliations

Soon will be listed here.

Abstract

Toll-like receptors (TLR) play a key role in innate immunity. To examine the ability of diverse TLRs to modulate hepatitis B virus (HBV) replication, HBV transgenic mice received a single intravenous injection of ligands specific for TLR2, TLR3, TLR4, TLR5, TLR7, and TLR9. All of the ligands except for TLR2 inhibited HBV replication in the liver noncytopathically within 24 h in a alpha/beta interferon-dependent manner. The ability of these TLR ligands to induce antiviral cytokines at the site of HBV replication suggests that TLR activation could represent a powerful and novel therapeutic strategy for the treatment of chronic HBV infection.

Citing Articles

Contradictory Mechanisms of rheumatoid arthritis and hepatitis B virus infection activation.

Zhu F, Wang M, Zhang X, Zhao G, Gao H, Zhou L Heliyon. 2025; 11(1):e41444.

PMID: 39850429 PMC: 11755052. DOI: 10.1016/j.heliyon.2024.e41444.

AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.

Dai D, Xie C, Zhong L, Liu S, Zhang L, Zhang H Signal Transduct Target Ther. 2024; 9(1):281.

PMID: 39384753 PMC: 11464762. DOI: 10.1038/s41392-024-01978-y.

Cell-type-specific expression analysis of liver transcriptomics with clinical parameters to decipher the cause of intrahepatic inflammation in chronic hepatitis B.

Wang J, Li Q, Qiu Y, Kitanovski S, Wang C, Zhang C Imeta. 2024; 3(4):e221.

PMID: 39135698 PMC: 11316924. DOI: 10.1002/imt2.221.

Toll-Like Receptor 7-Expressed Macrophages Are Involved in the Pathogenesis of Esophageal Achalasia and Esophagogastric Junction Outflow Obstruction.

Kaizuka M, Tatsuta T, Kawaguchi S, Yoshizawa T, Yoshida S, Tateda T Digestion. 2024; 105(6):436-447.

PMID: 39102805 PMC: 11633874. DOI: 10.1159/000540693.

Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents.

Lam R, Lim J World J Hepatol. 2024; 16(3):331-343.

PMID: 38577537 PMC: 10989302. DOI: 10.4254/wjh.v16.i3.331.

References

Kadowaki N, Ho S, Antonenko S, Malefyt R, Kastelein R, Bazan F . Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001; 194(6):863-9. PMC: 2195968. DOI: 10.1084/jem.194.6.863. View

Hayashi F, Smith K, Ozinsky A, Hawn T, Yi E, Goodlett D . The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001; 410(6832):1099-103. DOI: 10.1038/35074106. View

Pasquetto V, Wieland S, Uprichard S, Tripodi M, Chisari F . Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J Virol. 2002; 76(11):5646-53. PMC: 137053. DOI: 10.1128/jvi.76.11.5646-5653.2002. View

Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z . Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol. 2002; 169(1):10-4. DOI: 10.4049/jimmunol.169.1.10. View

Kimura K, Kakimi K, Wieland S, Guidotti L, Chisari F . Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002; 76(21):10702-7. PMC: 136645. DOI: 10.1128/jvi.76.21.10702-10707.2002. View

Kimura K, Kakimi K, Wieland S, Guidotti L, Chisari F . Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol. 2002; 169(9):5188-95. DOI: 10.4049/jimmunol.169.9.5188. View

Harte M, Haga I, Maloney G, Gray P, Reading P, Bartlett N . The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med. 2003; 197(3):343-51. PMC: 2193841. DOI: 10.1084/jem.20021652. View

Raschi E, Testoni C, Bosisio D, Borghi M, Koike T, Mantovani A . Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood. 2003; 101(9):3495-500. DOI: 10.1182/blood-2002-08-2349. View

Paik Y, Schwabe R, Bataller R, Russo M, Jobin C, Brenner D . Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology. 2003; 37(5):1043-55. DOI: 10.1053/jhep.2003.50182. View

10.

Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim S . Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 2003; 424(6950):743-8. DOI: 10.1038/nature01889. View

11.

Feng C, Scanga C, Collazo-Custodio C, Cheever A, Hieny S, Caspar P . Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol. 2003; 171(9):4758-64. DOI: 10.4049/jimmunol.171.9.4758. View

12.

Diebold S, Kaisho T, Hemmi H, Akira S, Reis e Sousa C . Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004; 303(5663):1529-31. DOI: 10.1126/science.1093616. View

13.

Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S . Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004; 303(5663):1526-9. DOI: 10.1126/science.1093620. View

14.

Lund J, Alexopoulou L, Sato A, Karow M, Adams N, Gale N . Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A. 2004; 101(15):5598-603. PMC: 397437. DOI: 10.1073/pnas.0400937101. View

15.

Wieland S, Thimme R, Purcell R, Chisari F . Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A. 2004; 101(17):6669-74. PMC: 404103. DOI: 10.1073/pnas.0401771101. View

16.

Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L . CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A. 2004; 101(27):10116-21. PMC: 454174. DOI: 10.1073/pnas.0403744101. View

17.

Muller U, Steinhoff U, Reis L, Hemmi S, Pavlovic J, Zinkernagel R . Functional role of type I and type II interferons in antiviral defense. Science. 1994; 264(5167):1918-21. DOI: 10.1126/science.8009221. View

18.

Guidotti L, Matzke B, Schaller H, Chisari F . High-level hepatitis B virus replication in transgenic mice. J Virol. 1995; 69(10):6158-69. PMC: 189513. DOI: 10.1128/JVI.69.10.6158-6169.1995. View

19.

Guidotti L, Ishikawa T, Hobbs M, Matzke B, Schreiber R, Chisari F . Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996; 4(1):25-36. DOI: 10.1016/s1074-7613(00)80295-2. View

20.

Cavanaugh V, Guidotti L, Chisari F . Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol. 1997; 71(4):3236-43. PMC: 191456. DOI: 10.1128/JVI.71.4.3236-3243.1997. View